These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 27733853)
41. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122 [TBL] [Abstract][Full Text] [Related]
42. Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression. Giurini EF; Madonna MB; Zloza A; Gupta KH Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740589 [TBL] [Abstract][Full Text] [Related]
43. [Responses with participation of toll-like receptors in protective immunity and in pathologic states]. Skivka LM; Pozur VV Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023 [TBL] [Abstract][Full Text] [Related]
44. Innate immune signaling in the myelodysplastic syndromes. Starczynowski DT; Karsan A Hematol Oncol Clin North Am; 2010 Apr; 24(2):343-59. PubMed ID: 20359630 [TBL] [Abstract][Full Text] [Related]
45. Therapeutic applications of toll-like receptors (TLRs) agonists in AML. Peng Y; Wang Y; Wang M; Lan J; Chen Y Clin Transl Oncol; 2022 Dec; 24(12):2319-2329. PubMed ID: 35962918 [TBL] [Abstract][Full Text] [Related]
46. Role of Toll-like receptors in microbiota-associated gastrointestinal cancer metastasis. Lu Q; Ding H; Li W J Cancer Res Ther; 2013 Nov; 9 Suppl():S142-9. PubMed ID: 24516050 [TBL] [Abstract][Full Text] [Related]
47. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824 [TBL] [Abstract][Full Text] [Related]
48. The role of toll-like receptors (TLRs) and their therapeutic applications in endometrial cancer. Arabian S; Boostan A; Darzi S Clin Transl Oncol; 2023 Apr; 25(4):859-865. PubMed ID: 36374404 [TBL] [Abstract][Full Text] [Related]
49. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Bhattacharya D; Yusuf N Int J Breast Cancer; 2012; 2012():716564. PubMed ID: 22295250 [TBL] [Abstract][Full Text] [Related]
50. Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers. Chandrasekar SA; Palaniyandi T; Parthasarathy U; Surendran H; Viswanathan S; Wahab MRA; Baskar G; Natarajan S; Ranjan K Pathol Res Pract; 2023 Aug; 248():154673. PubMed ID: 37453359 [TBL] [Abstract][Full Text] [Related]
51. Do you see what I see: Recognition of protozoan parasites by Toll-like receptors. Ghosh D; Stumhofer JS Curr Immunol Rev; 2013 Aug; 9(3):129-140. PubMed ID: 25383072 [TBL] [Abstract][Full Text] [Related]
52. Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies. Rozman M; Zidovec-Lepej S; Jambrosic K; Babić M; Drmić Hofman I Pathogens; 2023 Jan; 12(1):. PubMed ID: 36678440 [TBL] [Abstract][Full Text] [Related]
53. Toll-like receptors and prostate cancer. Zhao S; Zhang Y; Zhang Q; Wang F; Zhang D Front Immunol; 2014; 5():352. PubMed ID: 25101092 [TBL] [Abstract][Full Text] [Related]
54. Role of toll-like receptors in immune activation and tolerance in the liver. Nakamoto N; Kanai T Front Immunol; 2014; 5():221. PubMed ID: 24904576 [TBL] [Abstract][Full Text] [Related]
55. The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Leśniak M; Lipniarska J; Majka P; Kopyt W; Lejman M; Zawitkowska J Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851155 [TBL] [Abstract][Full Text] [Related]
56. Role of Toll-Like Receptors in Actuating Stem/Progenitor Cell Repair Mechanisms: Different Functions in Different Cells. Sallustio F; Curci C; Stasi A; De Palma G; Divella C; Gramignoli R; Castellano G; Gallone A; Gesualdo L Stem Cells Int; 2019; 2019():6795845. PubMed ID: 31089331 [TBL] [Abstract][Full Text] [Related]
57. Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment. Zheng R; Ma J Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365103 [TBL] [Abstract][Full Text] [Related]
58. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Sato Y; Goto Y; Narita N; Hoon DS Cancer Microenviron; 2009 Sep; 2 Suppl 1(Suppl 1):205-14. PubMed ID: 19685283 [TBL] [Abstract][Full Text] [Related]
59. Toll-like receptor activation: from renal inflammation to fibrosis. Yiu WH; Lin M; Tang SC Kidney Int Suppl (2011); 2014 Nov; 4(1):20-25. PubMed ID: 26312146 [TBL] [Abstract][Full Text] [Related]
60. Roles of toll-like receptors: From inflammation to lung cancer progression. Gu J; Liu Y; Xie B; Ye P; Huang J; Lu Z Biomed Rep; 2018 Feb; 8(2):126-132. PubMed ID: 29435270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]